郭建荣;卢慧琴;陈小非;

• 1:宁波大学医学院附属李惠利医院麻醉科

摘要(Abstract)：

<正>顺式阿曲库铵是构成阿曲库铵消旋混合物的10种同分异构体之一,为顺式旋光异构体。与阿曲库铵一样,它主要通过与运动终板胆碱能受体竞争性结合而发挥肌松作用。由于顺式阿曲库铵起效及恢复迅速,不释放组胺,对心血管影响小,无蓄积作用,代谢产物无毒性及肌松效应,得以在临床上广泛应用。我们就其药动学、药效学、临床应用和研究

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 郭建荣;卢慧琴;陈小非;

Email:

DOI: 10.19577/j.cnki.issn10074406.2010.03.022

参考文献(References)：

• [1]Adams WA,Mark-Senior J,Jones RS,et al.Qsatracurium in dogs with and without porto-systemic shunts[J].Vet Anaesth Anal,2006,33(1): 17.
• [2]Sparr HJ,Beaufout TM,Fuchs-Buder T.Newer neuromuscular blocking agents:how do they compare with established agents?[J].Drugs,2001, 61(7):919.
• [3]Dhonneur C,Cerf C,Lagneau F,et al.The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome[J]. Anesth Analg,2001,93(2):400.
• [4]Fodale V,Santamaria LB.Laudanosine,an atracurium and cisatracurium metabolite[J].Eur J Anaesthesiol,2002,19(7):466.
• [5]Schmith VD,Fiedler-Kelly J,Phillips L,et al.Prospecti ve use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium[J].Pharm Res,1997,14(1):91.
• [6]Sorooshian SS,Stafford MA,Eastwood NB,et al.Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients [J].Anesthesiology,1996,84(5):1083.
• [7]Imbeault K,Withington DE,Varin F.Pharmocokinetics and pharmacodynamics of a 0.1mg/kg dose of cisatracurium besylate in children during N_2O/O_2/propofol anesthesia[J].Anesth Analg,2006,102(3):738.
• [8]Garg RK.Anesthetic considerations in patients with hepatic failure[J]. Int Anesthesiol Clin,2005,43(3):45.
• [9]De Wolf AM,Freeman JA,Scott VL,et al.Pharmacokinetics and phamacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation[J].Br J Anaesth,1996,76(5):624.
• [10]Delia Rocca G,Pompei L,Coccia C,et al.Atracurium,cisatracurium, vecuronium and rocuronium in patients with renal failure[J].Minerva Anestesiol,2003,69(7-8):605.
• [11]闻大翔,陈锡明,杭燕南,等.顺式阿曲库铵在肾移植麻醉中的药效学研究[J].上海第二医科大学学报,2002,22(6):517.
• [12]Tobias JD,Johnson JO,Sprague K,et al.Effects of rapacuronium on respiratory function during genera]anesthesia:a comparison with cisatracurium[J].Anesthesiology,2001,95(4):908.
• [13]薛富善,廖旭,何农,等.年龄和性别对阿曲库铵量-效关系和恢复时相的影响[J].中国医学科学院学报,2001,23(1):54.
• [14]Adamus M,Gabrhelik T,Marek O.Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium[J].Eur J Anaesthesiol,2008,25(7):589.
• [15]Bergeron L,Bevan DR.Berrill A,et al.Concentration-effect relationship of cis-atracurium at three different dose levels in the anesthetized patient [J].Anesthesiology,2001,95(2):314.
• [16]上官王宁,连庆泉,李军,等.小儿不同剂量顺式阿曲库铵的肌松作用[J].中华麻醉学杂志,2007,27(1):54.
• [17]黄艾平,孔高茵,刘景诗,等.顺式阿曲库铵应用于不同年龄小儿的药效学研究[J].药物与临床,2007,18(29):2281.
• [18]Adamus M,Belohlavek R,Koutna J,et al.Cisatracurium vs rocuronium: a prospective,comparative,randomized study in adult patients under total intravenous anaesthesia[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech,2006,150(2):333.
• [19]闻大翔,蒋茹,杭燕南,等.顺式阿曲库铵、维库溴铵在老年患者中的药效学研究[J].中华老年医学杂志,2004,23(5):313.
• [20]上官王宁,连庆泉,陈小玲,等.顺式阿曲库铵对手术患儿的肌松作用[J].中华麻醉学杂志,2005,25(5):395.
• [21]Kenaan CA,Estacio RL,Bikhazi GB.Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia[J].J Clin Anesth,2000,12(3):173.
• [22]Arain SR,Kem S,Ficke DJ,et al.Variability of duration of action of neuromuscular-blocking drugs in elderly patients[J].Acta Anaesthesiol Scand,2005,49(3):312.
• [23]Jellish WS,Brody M,Sawicki K,et al.Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics[J]. Anesth Analg,2000,91(5):1250.
• [24]Belmont M,Lien CA,Quessy S,et al.The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia[J].Anesthesiology,1995,82(5):1139.
• [25]Mirinejad M,Azarfarin R,Asl AA.Cisatracurium in cardiac surgery continuous infusion vs bolus administration[J].Middle East J Anesthesiol, 2007,19(3):563.
• [26]Schmidt J,Albrecht S,Petterich N,et al.Priming technique with cisatracurium onset time at the laryngeal muscles[J].Anaesthesist, 2007,56(10):992.
• [27]Kirov K,Motamed CDecailliot F,et al.Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis[J].Acta Anaesthesiol Scand,2004,48(5):577.
• [28]Selcuk M,Celebioglu B,Celiker V,et al.Infusion and bolus administration of cisatracurium effects on histamine release[J].Middle East J Anesthesiol,2005,18(2):407.
• [29]Sanchez Palacios A,Ortiz Ponce M,Rodriguez Perez A,et al.Modification of mediators of immune reaction after general anaesthesia[J].Allergol Immunopathol,2004,32(6):352.
• [30]Hans P,Welter P,Dewander PY,et al.Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery[J].Acta Anaesthesiol Belg,2004,55(2):129.
• [31]Abdulatiff M,EI-Sanabarv M.Edrophonium antagonism of cisatracurium induced neuromuscular block:dose requirements in children and adults [J].Anaesth Intensive Care,2001,29(4):364.
• [32]Aguib M,Riad W.Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block[J].Can J Anaesth,2000,47(11):1074.